Gene · 3313
Papers3,383
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,383
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Get Closer to the World of Contact Sites: A Beginner's Guide to Proximity-Driven Fluorescent Probes. | Contact (Thousand Oaks) | 2022 | 37366505 | PubTator, text mining | PubMed |
| DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden. | Front Oncol | 2022 | 36713578 | PubTator, text mining | PubMed |
| Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. | Front Immunol | 2022 | 36700224 | PubTator, text mining | PubMed |
| Genetic polymorphisms of Ca2+ transport proteins and molecular chaperones in mitochondria-associated endoplasmic reticulum membrane and non-alcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2022 | 36686460 | PubTator, text mining | PubMed |
| Identification of oxidative stress-related genes and potential mechanisms in atherosclerosis. | Front Genet | 2022 | 36685865 | PubTator, text mining | PubMed |
| Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential. | Front Cardiovasc Med | 2022 | 36684555 | PubTator, text mining | PubMed |
| Advances in Human Mitochondria-Based Therapies. | Int J Mol Sci | 2022 | 36614050 | PubTator, text mining | PubMed |
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
| Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities. | Cells | 2022 | 36611952 | PubTator, text mining | PubMed |
| Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches. | Front Endocrinol (Lausanne) | 2022 | 36589857 | PubTator, text mining | PubMed |
| A new model for fatty acid hydroxylase-associated neurodegeneration reveals mitochondrial and autophagy abnormalities. | Front Cell Dev Biol | 2022 | 36589738 | PubTator, text mining | PubMed |
| Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients. | Cancer Cell Int | 2022 | 36585652 | PubTator, text mining | PubMed |
| The effect of emotion regulation on happiness and resilience of university students: The chain mediating role of learning motivation and target positioning. | Front Psychol | 2022 | 36571032 | PubTator, text mining | PubMed |
| The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity. | Front Immunol | 2022 | 36569866 | PubTator, text mining | PubMed |
| The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease. | Pharmaceutics | 2022 | 36559254 | PubTator, text mining | PubMed |
| Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients. | Metabolites | 2022 | 36557263 | PubTator, text mining | PubMed |
| Challenging Cellular Homeostasis: Spatial and Temporal Regulation of miRNAs. | Int J Mol Sci | 2022 | 36555797 | PubTator, text mining | PubMed |
| Molecular Regulation of Concomitant Lower Urinary Tract Symptoms and Erectile Dysfunction in Pelvic Ischemia. | Int J Mol Sci | 2022 | 36555629 | PubTator, text mining | PubMed |
| Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. | Cancers (Basel) | 2022 | 36551580 | PubTator, text mining | PubMed |
| GRP75 Modulates Endoplasmic Reticulum-Mitochondria Coupling and Accelerates Ca2+-Dependent Endothelial Cell Apoptosis in Diabetic Retinopathy. | Biomolecules | 2022 | 36551205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/papers?page=26